Dr. Liau is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Wasserman Building
300 Stein Plaza, Suite 564
Los Angeles, CA 90095Phone+1 310-825-5111Fax+1 310-267-9449- Is this information wrong?
Summary
- Dr. Linda Liau is a neurosurgeon in Los Angeles, CA and is affiliated with multiple hospitals in the area, including Ronald Reagan UCLA Medical Center and UCLA Medical Center-Santa Monica. She received her medical degree from Stanford University School of Medicine and has been in practice 27 years. She specializes in brain & spinal tumor and skull base and is experienced in glioblastoma, neurosurgical oncology, primary brain tumors, brainstem glioma, and skull base surgery.
Education & Training
- UCLA Anderson School of ManagementMBA, Poets & Quants Best & Brightest Executive MBAs, 2014 - 2016
- UCLAPhD, Neuroscience, 1995 - 1999
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurological Surgery, 1991 - 1998
- Stanford University School of MedicineClass of 1991, MD
- Brown UniversityBS, BA, Biochemistry, Political Science, Magna Cum Laude, 1984 - 1987
Certifications & Licensure
- CA State Medical License 1993 - 2025
- American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- Elected Member National Academy of Medicine, 2018
- Super Doctors Southern California, 2016-2018
- Top Doctors:LA Area Castle Connolly, 2013-2018
- Join now to see all
Clinical Trials
- Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer Start of enrollment: 2006 Dec 01
- Vaccine Therapy in Treating Patients With Malignant Glioma Start of enrollment: 2003 Jun 01
- Vaccine Therapy in Treating Patients With Malignant Glioma Start of enrollment: 2006 May 01
- Join now to see all
Publications & Presentations
PubMed
- D-2-HG Inhibits IDH1mut Glioma Growth via FTO Inhibition and Resultant m6A Hypermethylation.Sean T Pianka, Tie Li, Terry J Prins, Blaine S C Eldred, Bryan M Kevan, Haowen Liang, Serendipity Zapanta Rinonos, Harley I Kornblum, David A Nathanson, Matteo Pellegr...> ;Cancer Research Communications. 2024 Mar 22
- Single-nucleus expression characterization of non-enhancing region of recurrent high-grade glioma.Kunal S Patel, Kaleab K Tessema, Riki Kawaguchi, Lindsey Dudley, Alvaro G Alvarado, Sree Deepthi Muthukrishnan, Travis Perryman, Akifumi Hagiwara, Vivek Swarup, Linda ...> ;Neuro-Oncology Advances. 2024 Jan 25
- dCas9/CRISPR-based methylation of O-6-methylguanine-DNA methyltransferase enhances chemosensitivity to temozolomide in malignant glioma.Serendipity Zapanta Rinonos, Tie Li, Sean Thomas Pianka, Terry J Prins, Blaine S C Eldred, Bryan M Kevan, Linda M Liau, Phioanh Leia Nghiemphu, Timothy F Cloughesy, Al...> ;Journal of Neuro-Oncology. 2024 Jan 1
- Join now to see all
Journal Articles
- Heterogeneity Within the PF-EPN-B Ependymoma SubgroupAndrew Grossbach, Vijay Ramaswamy, Benjamin Lu, Mariarita Santi, Caterina Giannini, Linda M Liau, Terri S Armstrong, Sarah Leary, Matthias A Karajannis, Kenneth Aldape..., Acta Neuropathologica
- Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1/PD-L1 mechanism in glioblastomaAntonios JP, Soto H, Everson RG, Moughon D, Orpilla JR, Shin NP, Sedighim S, Treger J, Odesa S, Tucker A, Yong WH, Li G, Cloughesy TF, Liau LM, Prins RM, Neuro Oncol, 1/1/2017
- Incidence, survival, pathology, and genetics of adult Latino Americans with glioblastomaShabihkhani M, Telesca D, Movassaghi M, Naeini YB, Hojat SA, Gupta D, Lucey GM, Ontiveros M, Wang MW, Hanna LS, Sanchez DE, Mareninov S, Khanlou N, Vinters HV, Bergsne..., J Neurooncol, 1/1/2017
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- TCR sequencing can identify and track tumor-specific T-cell populations and is a predictive biomarker of response to DC vaccination in glioblastoma patientsSedighim S, Hsu M, Wang T, Everson RG, Tucker A, Antonios JP, Du L, Emerson R, Yusko E, Sanders C, Robins H, Yong W, Davidson TB, Li G, Liau LM, Prins RM, 107th American Association for Cancer Research (AACR) Annual Meeting, Cancer Research, New Orleans, LA, 1/1/2016
- Study of 82 glioblastoma autopsies including subset evaluation of PD-1 and PDL-1Abdaljaleel M, Movassaghi M, Tashjian RS,... Liau LM, Yong WH, 92nd Annual Meeting of the American Association of Neuropathologists, Baltimore, MD, 1/1/2016
- The Toca 7 study: Phase IB study of Toca511, a live gama retrovirus, and Toca FC, an extended-release formulation of 5-fluorocytosine combined with standard of care in...Vogelbaum MA, Lassman AB, Lee I,… Liau LM…, Cloughesy TF, 21st Annual Meeting of the Society for Neuro-Oncology, Neuro-Oncol, Phoenix, AZ, 1/1/2016
- Join now to see all
Press Mentions
- AANS/CNS Cerebrovascular Section and American Society of Stereotactic and Functional Neurosurgery Contribute to SNS Neurosurgeon-Scientist Training ProgramJanuary 24th, 2023
- Brain Tumor Nonprofit StacheStrong Donates $110,000 for the Launch of the SNS Neurosurgeon-Scientist Training ProgramJanuary 10th, 2023
- Researchers Announce Breakthrough in Brain Cancer Vaccine TrialJanuary 7th, 2023
- Join now to see all
Professional Memberships
- Member
- Fellow
Hospital Affiliations
- Ronald Reagan UCLA Medical CenterLos Angeles, California
- UCLA Medical Center-Santa MonicaSanta Monica, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: